EICHORThis page counts public registry records — it is not a list of trials you can join.
Studies recruiting near Broadmeadow →
Never medical advice — always discuss trial participation with your own doctor first.
Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.
Verify this profile →Public research footprint of Genesis Research Services, compiled from the ClinicalTrials.gov public registry.
Genesis Research Services appears in 27 registered studies on ClinicalTrials.gov, spanning 2015–2025, run by 19 different lead sponsors, covering 42 distinct drugs and biologics. The record is weighted toward Phase 3 and Phase 2 (8 and 8 phase tags). 4 studies are recruiting now.
Osteoarthritis, Knee · Chronic Pain · Rheumatoid Arthritis · Headache Migraine Chronic
Registry entries at this facility span 2015–2025. Phase tags — a study spanning two phases counts under both:
19 different lead sponsors appear. Most frequent:
| Pfizer | 5 studies |
| AbbVie | 2 studies |
| Gilead Sciences | 2 studies |
| ShiraTronics | 2 studies |
| Taiwan Liposome Company | 2 studies |
| Barinthus Biotherapeutics | 1 study |
| Biotronik, Inc. | 1 study |
| Bioventus LLC | 1 study |
| Doron Therapeutics Inc. | 1 study |
| Eli Lilly and Company | 1 study |
…and 9 more sponsors with fewer entries.
42 distinct investigational and approved compounds appear (dose and formulation variants combined). A ×N marks a compound appearing in more than one entry here.
Research staff — enter your work email to view the full list.
Compiled from public registry records (ClinicalTrials.gov) as of August 11, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.
